Varex Imaging (VREX) Liabilities and Shareholders Equity (2016 - 2026)
Varex Imaging's (VREX) quarterly Liabilities and Shareholders Equity came in at $1.1 billion in Q2 2026, down 19.76% year-on-year from $1.4 billion in Q2 2025, and down 0.78% on a QoQ basis from $1.1 billion in Q1 2026.
Varex Imaging (VREX) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $1.1 billion in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 19.76% year-over-year to $1.1 billion in Q2 2026; TTM through Apr 2026 was $4.4 billion, a 15.28% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 8.75% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for VREX reached as high as $1.4 billion in Q2 2025 and fell as low as $1.1 billion in Q3 2025.
- Historically, Liabilities and Shareholders Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
- Across the five-year window, Liabilities and Shareholders Equity grew 8.46% in 2025 and fell 19.76% in 2026, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then increased by 5.2% to $1.2 billion in 2023, then decreased by 2.31% to $1.2 billion in 2024, then dropped by 8.75% to $1.1 billion in 2025, then slipped by 1.63% to $1.1 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Varex Imaging | 463.68 Mn | 375.38 Mn | 72.60 Mn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.09 Bn |
| Jan 2, 2026 | 1.10 Bn |
| Oct 3, 2025 | 1.11 Bn |
| Jul 4, 2025 | 1.07 Bn |
| Apr 4, 2025 | 1.36 Bn |
| Jan 3, 2025 | 1.33 Bn |
| Sep 27, 2024 | 1.21 Bn |
| Jun 28, 2024 | 1.25 Bn |
| Mar 29, 2024 | 1.25 Bn |
| Dec 29, 2023 | 1.24 Bn |
| Sep 29, 2023 | 1.25 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.19 Bn |
| Dec 30, 2022 | 1.18 Bn |
| Sep 30, 2022 | 1.18 Bn |
| Jul 1, 2022 | 1.16 Bn |
| Apr 1, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.14 Bn |
| Oct 1, 2021 | 1.15 Bn |
| Jul 2, 2021 | 1.16 Bn |